TH Open (Jul 2022)

Emicizumab-induced photosensitivity

  • Pedro Asensi Cantó,
  • Mercedes Rodríguez Serna,
  • Pilar Lloret Madrid,
  • Jürgen Solís Ruiz,
  • Ana Rosa Cid Haro,
  • Santiago Bonanad Boix,
  • Saturnino Haya Guaita

DOI
https://doi.org/10.1055/s-0042-1749092
Journal volume & issue
Vol. 06, no. 03
pp. e154 – e155

Abstract

Read online

Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our knowledge, this side effect had not been communicated until present.

Keywords